A monthly podcast with a focus on the use and application of T and B cell receptor repertoires in diagnostics and other clinical settings.
On AIRR - Immune receptors in the clinic
Claim This Podcastby AIRR-Community
5.0(3 reviews)
20 episodes
Updated Bi-weekly
Accepts GuestsHas Sponsors
19
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement32
Podcast Overview
A monthly podcast with a focus on the use and application of T and B cell receptor repertoires in diagnostics and other clinical settings.
Language
🇺🇲
Publishing Since
1/24/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
19
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement32
7
Excellent Areas
0
Good Performance
12
Growth Opportunities
excellent
Episode Length
40 minutes
Performing excellently!
poor
Publishing Consistency
Every 69 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for On AIRR - Immune receptors in the clinic
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 18, 2026
On AIRR 20: Adventures in Antibody Discovery with Williamson, Carnahan, and Vogt
In Episode 20 of On AIRR, Dr. Lauren Williamson and Dr. Robert Carnahan, both from Vanderbilt University Medical Center, and Dr. Matthew Vogt, from the University of North Carolina, share extreme stories of sample collection that reveal how cutting-edge therapeutic antibody development depends as much on donor generosity and complex global logistics as on scientific innovation. From dramatic efforts to secure the first U.S. donor samples in the early days of the COVID-19 pandemic, to rescuing lost samples from airport corridors and navigating international politics, these stories highlight the critical timing windows, global coordination, and human collaboration required to develop life-saving therapeutics. Throughout these extraordinary stories runs a thread of human generosity, demonstrating how crisis can bring out the best of human nature. Comments are welcome to the inbox of onairr@airr-community.org or on social media under the tag #onAIRR. Further information can be found here: https://www.antibodysociety.org/the-airr-community/airr-c-podcast. The episode is hosted by Dr. Ulrik Stervbo and Dr. Zhaoqing Ding. Announcements and links Lauren Williamson https://www.vumc.org/crowe-lab/person/lauren-williamson-phd Robert Carnahan https://www.vumc.org/crowe-lab/person/robert-carnahan-phd Matthew Vogt https://www.vogtviruslab.com Other: ReVAMPP https://revampp.org Adaptive Immune Receptor Repertoire Community (AIRR-C) https://www.airr-community.org The Antibody Society (TAbS) https://www.antibodysociety.org AIRR-C Seminar Series: https://www.antibodysociety.org/the-airr-community/airr-community-seminar-series/
September 5, 2025
On AIRR 19: Pandemic preparedness through antibody discovery with Williamson, Carnahan, and Vogt.
Episode 19 of onAIRR features a lively and insightful conversation with three outstanding scientists committed to advancing pandemic preparedness. Dr. Lauren Williamson and Dr. Robert Carnahan, both from Vanderbilt University Medical Center, and Dr. Matthew Vogt, from the University of North Carolina, share their passion for viral immunology and the art of discovering and developing therapeutic antibodies. onAIRR’s guests provide a behind-the-scenes look at how collaborative research is shaping the future of global health. They introduce the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) research network, a major NIH-funded initiative aimed at strengthening pandemic readiness. The conversation explores the use of prototype pathogen approaches to identifying broadly neutralizing antibodies against high-priority viral families, the challenges of balancing breadth versus potency in therapeutic antibodies, and innovative screening methodologies that could transform our ability to respond to future pandemics. Comments are welcome to the inbox of onairr@airr-community.org or on social media under the tag #onAIRR. Further information can be found here: https://www.antibodysociety.org/the-airr-community/airr-c-podcast. The episode is hosted by Dr. Ulrik Stervbo and Dr. Zhaoqing Ding. Announcements and links Lauren Williamson https://www.vumc.org/crowe-lab/person/lauren-williamson-phd Robert Carnahan https://www.vumc.org/crowe-lab/person/robert-carnahan-phd Matthew Vogt https://www.vogtviruslab.com ReVAMPP https://revampp.org ReVAMPP https://www.niaid.nih.gov/news-events/nih-awards-establish-pandemic-preparedness-research-network "Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness” https://doi.org/10.1093/infdis/jiac296 Adaptive Immune Receptor Repertoire Community (AIRR-C) https://www.airr-community.org The Antibody Society (TAbS) https://www.antibodysociety.org AIRR-C Seminar Series https://www.antibodysociety.org/the-airr-community/airr-community-seminar-series
June 9, 2025
On AIRR 18: From single-chain TCR sequencing to paired high-throughput methods with Paul Thomas
Dr. Paul Thomas discusses his evolution from immunoparasitology to pioneering TCR repertoire sequencing, including the development of high-throughput paired sequencing methods like TIRTL-seq, in an interview with Dr. Ulrik Stervbo and Dr. Zhaoqing Ding.
20 total episodes available
Recent guests on On AIRR - Immune receptors in the clinic
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Paul Thomas
Guest
Deep-dive analytics for On AIRR - Immune receptors in the clinic
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is On AIRR - Immune receptors in the clinic?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.